ChIP assays were performed on hearts obtained from 2-3 month old male mice. Specifically, hearts were isolated, weighed and homogenized for a few seconds (until no tissue clumps) in cold PBS using a Brinkmann polytron homogenizer. The samples were centrifuged at 2000 rpm for 2 min at 4°C and the cell pellets were resuspended in cell lysis buffer (5 mM HEPES pH 8, 85 mM KCl, 0.5% NP-40) containing a protease inhibitor cocktail (Roche) and incubated at 4°C for 15 min with rotation. Following centrifugation at 2000 rpm for 2 min at 4°C, the nuclear pellets were resuspended in PBS containing formaldehyde (1% final) and DNA-protein crosslinking was allowed to occur at room temperature for 20 min with rotation. Samples were then centrifuged at 2000 rpm for 2 min at 4°C and the nuclear pellets were washed twice with cold PBS and resuspended in nuclei lysis buffer (50 mM Tris-HCl, pH 8.1, 10 mM EDTA, 1% SDS) supplemented with protease inhibitors (Roche). The resuspended nuclear pellets were pooled and sonicated on ice at power 10 for 30 sec pulses using a VirSonic 100 (Virtis) sonicator at 30 sec intervals to prevent the samples from heating. Sonicated material was centrifuged at 13000 rpm for 15 min at 4°C. For standard ChIP experiments, 10% input samples were prepared by incubating sonicated material corresponding to 0.015 g of starting cardiac weight and decrosslinked (1% SDS, 0.1 M NaHCO 3 ) at 65°C overnight. Thereafter, the 10% inputs were purified using the QIAquick Spin Kit (Qiagen). For antibody-enriched and no-antibody control samples, chromatin cor responding to 0.15 g of initial heart mass was diluted in 2.5X ChIP dilution buffer (0.5% Triton X-100, 2 mM EDTA, 100 mM NaCl, 20 mM Tris-HCl, pH 8.1) and pre-cleared using 50 µl of a 50% slurry of salmon sperm DNA/protein A beads (Upstate) for 1 h at 4°C. Precleared chromatin was either immunoprecipitated (target enriched material) or not (no antibody control) overnight with an anti-ERRα polyclonal antibody developed in our laboratory or with a purified specific anti-ERRγ polyclonal antibody with subsequent addition of 50 µl of a 50% slurry of salmon sperm DNA/protein A beads for 2 h at 4°C. The 2 beads were washed sequentially for 10 min at 4°C with three different buffers requiring centrifugation at 2000 rpm at 4°C after each wash. Initially, buffer I (1% Triton X-100, 0.1% SDS, 150 mM NaCl, 2 mM EDTA, pH 8.0, 20 mM Tris-HCl, pH 8.1) was used, then buffer II (1% Triton X-100, 0.1% SDS, 500 mM NaCl, 2 mM EDTA, pH 8.0, 20 mM Tris-HCl, pH 8.1) and finally with buffer III (1% NP-40, 0.25 mM LiCl, 1% Na-deoxycholate, 1 mM EDTA, pH 8.0, 10 mM Tris-HCl, pH 8.1). The beads were next washed briefly with TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, pH 8.0) and decrosslinked (1% SDS, 0.1 M NaHCO 3 ) at 65°C overnight. Decrosslinked samples were purified using the QIAquick Spin Kit (Qiagen). For ChIP-on-chip analyses, the 10% inputs, immunoprecipitated and noantibody control samples were prepared as described above for standard ChIP experiments with the following modifications: for the 10% inputs, sonicated material corresponding to 0.15 g of starting cardiac weight was used; for immunoprecipitated and no-antibody samples, sonicated material corresponding to 1.5 g initial heart mass was used; a volume of 400 µl of a 50% slurry of salmon sperm DNA/protein A beads was used for both a 2 h pre-clear and 3 h antibody incubation prior to sequential washing with wash buffers.
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Genome-wide Location Analysis
Triplicate mouse heart ERRα and ERRγ genome-wide location analysis experiments were performed using ChIP samples prepared as described above. Sample preparation of enriched and input control material for hybridizations to mouse promoter microarrays involves ligation-mediated PCR (LM-PCR) and Cy-dye labeling. First, the 10% inputs were diluted with H 2 O to a total of 55 µl to the percentage required for the input samples to read at the same Q-PCR cycle as that for the enriched samples using control primers. Then, 55 µl of non-diluted purified enriched material and diluted control input samples were separately added to a 55 µl mixture containing 11 µl NEB buffer 2 (10X), 0.5 µl BSA (10 mg/ml), 1 µl 10 mM dNTP mix, 0.2 µl T4 DNA polymerase (3U/µl) and 42.3 µl of H 2 O. The mixtures were incubated at 12°C for 20 min followed by addition of 12 µl of a solution containing 11.5 µl 3 M NaOAc, pH 5.2 and 0.5 µl glycogen (20 mg/ml). The samples were vortexed briefly and 120 µl of phenol/chloroform/isoamyl was added. The samples were vortexed again and centrifuged for 5 min at 13000 rpm at RT. The upper phase was transferred to a new tube followed by addition of 2 volumes of cold ethanol. The samples were vortexed and precipitated at -80°C for 1 h. The precipitated material was centrifuged at 13000 rpm, 4°C for 30 min, the pellets were air-dried and then resuspended with a 20 µl mixture containing 2 µl 10X T4 DNA ligase buffer, 6.5 µl annealed linkers (15 µM) (Ren et al., 2000) , 0.5 µl 0.1 M ATP, 1 µl T4 DNA ligase (400U/µl) and 10 µl H 2 O. The resuspended samples were incubated at 16°C overnight. The next day, a 20 µl solution containing 13.5 µl H 2 O, 4 µl 10X Thermopol buffer, 1.25 µl 10 mM dNTP mix and 1.25 µl of 40 uM oligo oJW102 (Ren et al., 2000) was added. The samples were initiated to an LM-PCR program consisting of 4 min at 55°C, 3 min at 72°C, 2 min at 95°C, 28 cycles of 30 sec at 95°C, 30 sec at 60°C and 1 min at 72°C, followed by 5 min at 72°C and kept at 4°C until ready. The PCR program was paused once step 1 reached 2 min at 55°C, then a 10 µl solution comprised of 8 µl of H 2 O, 1 µl of 10X Thermopol buffer and 1 µl TAQ (5U/µl, Invitrogen) was added and the PCR run was continued. The LM-PCR samples were purified by QIAquick Spin kit and eluted twice with 30 µl of elution buffer provided in the kit. Purified enriched and input control samples were labeled with Cy5 and Cy3 dyes (Invitrogen), respectively. For each ChIP-on-chip sample, 1 µg purified LM-PCR'd sample was placed into two 1.5 ml eppendorfs (2µg each of enriched and control input samples needed). Next, 20 µl 2.5X Random Primers (BioPrime Kit) was added and the samples were incubated at 95°C for 5 min. The samples were cooled on ice and 5 µl dUTP was added. Then, 1 µl of Cy5 or Cy3 was added with subsequent addition of 1 µl Klenow to each tube. The samples were incubated at 37°C for 2 h covered with aluminum foil. The samples were then purified using the Invitrogen BioPrime kit and 2 µg of each sample was eluted with at total of 100 µl. To the purified samples, 1/10 volume 3M NaOAc, pH 5.2 and 2.5X volume of cold ethanol was added and the samples were precipitated at -80°C for 2 h. Subsequently, the samples were centrifuged at 4°C for 30 min at maximum speed and the pellets were washed with 70% ethanol, air-dried and stored at -20°C ready for hybridization.
Microarray slides containing 18,657 promoter regions spanning from 800 bp upstream to 200 bp downstream of promoter transcriptional start sites were blocked for 20 min in a 250 ml solution containing 4 g succinic anhydride, 239 ml 1-methyl-2-pyrrolidinone and 11 ml boric acid, pH 8. The slides were then emerged first briefly then for 20 sec into a dish containing 0.2% SDS solution, followed by 20 sec in RT water, 2 min in 95°C water and finally for a few seconds in RT water prior to centrifugation at 1500 rpm for 3 min. Cy5 labeled enriched material was resuspended in 5 µl H 2 O and combined with Cy3 labeled nonenriched material. Then, 20 µl human Cot-1 DNA (1 mg/ml) and 5 µl yeast tRNA (8 mg/ml) were added to the samples, mixed and then dried using a speed vac. The dried samples were resuspended in 50 µl hybridization buffer prepared by mixing 125 µl formamide (25% final), 125 µl 20X SSC (5X final), 5 µl 10% SDS (0.1% final), 100 µl BSA (20% final), and 145 µl H 2 O. The samples were incubated at 95°C for 5 min and kept on a 50°C hot plate after a quick spin. About 47-48 µl from each sample was transferred onto a blocked mouse 19K promoter microarray slide, placed into a hybridization chamber and incubated at 50°C for at least 20 h. The microarrays were then washed consecutively with three different washing buffers with agitation. First, the arrays were washed for 15 min in Wash I solution (2X SSC, 0.1% SDS), twice for 2 min in Wash II solution (0.1X SSC, 0.1% SDS) and twice for 1 min in Wash III solution (0.1X SSC). The slides were then dried by centrifugation at 1500 rpm for 3 min, scanned and a macro was run to calculate p-values and binding ratios for the hybridized promoters on the mouse microarrays.
The P value threshold used to select target promoters for further analyses was determined empirically by testing randomly selected targets by standard ChIP/qPCR. Based on these experiments, we used P ≤0.01 because our estimated false-positive rate was <7.5% (genes tested = 49) using this threshold compared to a false-positive rate of > 35% at P 0.01 to 0.02 (genes tested = 55) for both antibodies.
Mouse Promoter Microarray Design
The strategy adopted to design our mouse promoter microarray is similar to the one used for our human promoter array (Laganière et al., 2005) . Briefly, full length cDNAs were extracted from Refseq and mammalian gene collection (MGC) databases and filtered to eliminate redundancy and incomplete cDNAs. Their transcription start sites (TSS) were then located using the University of California at Santa Cruz (UCSC) genome browser (Karolchik et al., 2003) and the sequence ranging from 800 base pairs (bp) upstream to 200 bp downstream of the TSS was extracted using the UCSC database assemblage May 2004 (Karolchik et al., 2003 . Primer pairs were designed using the Primer3 algorithm (Rozen and Skaletsky, 2000) and the specificity tested in silico using the vPCR algorithm (Lexa et al., 2001) . When the primer pair gave no satisfactory vPCR results, a new primer pair was designed using primer3 and tested again. The process was iterated 3 times to generate primer pairs predicted to be efficient to amplify promoter regions from mouse genomic DNA for almost all of our selected genes. This strategy was adopted after preliminary results showed that a more simple primer design approach did not generate good results when we tried to amplify promoter regions from mouse genomic DNA. This primer design pipeline allows us to design primer pairs to amplify promoter regions from mouse genomic DNA with a success rate of about 80%. At the date of the download (November 2004) 17947 RefSeq and 16,390 MGC entry were retrieved after the filtering process 18,892 of them were selected and submitted to primer design. Finally primers were obtains for 18,655 promoters.
Generation of Constructs
Mouse promoter sequences were obtained from the UCSC genome browser database, and cloned from C57BL/6J mouse genomic DNA using high-fidelity PCR. Promoters Mtch2 (-1893 to +127), Cycs (-1110 to +68), Timm8b (-1334 to +47), Got1 (-1000 to +60), Oxt (-1339 to +9) and Pah (-2660 to +44) were cloned into pGL3 basic, while Pias3 regulatory region (+2002 to +3338) was cloned into pGL4.20, as was the Cycs promoter for the CREB cotransfection experiment. For mutation studies, the ERREs at -169 and -105 from the TSS of the Oxt and Pah promoters. respectively were replaced by the sequence CGCTATGCA. CMX-ERRα and CMX-ERRγ constructs have previously been described (Laganière et al., 2004 ) and pcDNA3-HA-PGC1α was a gift from A. Kralli (La Jolla, CA). The adenovirus expressing GFP (Ad-GFP) or ERRα (Ad-ERRα) have been previously described (Huss et al., 2002) , and the Ad-ERRγ was constructed using the same Ad-Easy system by subcloning the full length HA-ERRγ insert from the pSG5-ERRγ expression construct provided by M. Stallcup (USC). RcCMV-STAT1c and STAT3c were gifts from Dr. David Frank (Harvard). CREB and A-CREB, a dominant negative CREB incapable of binding DNA (Ahn et al., 1998) were gifts from Eric Nestler (University of Texas Southwestern).
Reporter Assays
Cos-1 cells were transfected using FUGENE in 12-well plates with 300-400 ng luciferase reporter, 100 ng total CMX expression vector (50+50 ng for ERRα and ERRγ together), 100 ng CMV β-galactosidase, 300 ng of HA-PGC1α or pcDNA3. Cells were harvested and assayed for luciferase activity 24 h post-transfection. The CREB/Cycs cotransfection experiment was performed in 293T cells using 100 ng ERRα with 100 ng CREB/A-CREB and 300 ng HA-PGC1α expression vectors. Pias3 reporter assays were performed in HEK293 cells with either 50 ng ERRα, 200 ng STAT1c/3c and 300 ng HA-PGC1α expression vectors or with 100 ng ERRα, 100 ng CREB/A-CREB and 300 ng HA-PGC1α expression vectors. Experiments were performed in triplicate and each experiment was replicated multiple times.
Electromotility Shift Assay
For dimerization studies, both ERRα and ERRγ∆N-terminus (amino acids 1 to 47 deleted) were co-in vitro transcribed/translated. EMSAs were performed as previously described (Tremblay et al., 1997) using the 32 P-labelled DNA probe 5'-TCGACGCTTTTAAGGTCATATCCG-3' (Barry et al., 2006) . For mutation studies, 32 Plabelled WT (wild-type) or mutated ERRE (with the identified underlined ERREs replaced with the non-ERRE sequence CGCTATGCA), DNA probes derived from the sequence of the following mouse promoters:
Coimmunoprecipitation and Immunoblotting Assays
For coimmunoprecipitation studies, hearts from wild-type and ERRα null mice were isolated, washed in PBS and homogenized in lysis buffer (10 mM Tris pH 8.0, 150 mM NaCl, 1% Triton X-100 and 60 mM n-octyl glucoside (Sigma) containing a protease inhibitor cocktail (Roche)). Heart lysates were incubated at 4°C with rotation for 1 h and centrifuged at 13,000 rpm for 10 min at 4°C. Four mg each of wild-type and ERRα null heart lysate was precleared with protein G-sepharose for 1 h at 4°C with rotation. The supernatants were collected following centrifugation at 13,000 rpm for 15 sec at 4°C and incubated for 90 min at 4°C with rotation with either anti-ERRα or anti-ERRγ polyclonal antibody. Subsequently, protein G-sepharose was added to the lysates and the samples were left to rotate at 4°C for 1 h. The immunoprecipitates were washed 5 times with lysis buffer and eluted in loading buffer and boiled for 5 min. The samples were separated on a 10% SDS-PAGE gel, transferred onto PVDF membranes (Amersham Biosciences) and blocked overnight at 4°C in PBS-T (phosphate-buffered saline and 0.1% Tween 20) containing 5% skim milk. Membranes were incubated for 1 h with either anti-ERRα (1:10,000) or anti-ERRγ (1:2,000) antisera diluted in PBS-T containing 5% skim milk. Following 3 washes in PBS-T containing 5% skim milk, the membranes were incubated for 1 h with rabbit IgG TrueBlot (eBioscience, diluted 1:2000 in PBS-T containing 5% skim milk) and the proteins were detected using Lumi-Light Western Blotting Substrate (Roche). Immunoblotting for detection of phospho-ACC, ACC, phospho-AMPKα, AMPKα, AMPKβ1 and β2, and α-tubulin were done in a similar manner using 100 µg of wild-type and ERRα null mouse heart lysate using antiphospho-ACC (Ser79) antibody (#3661, Cell Signaling, 1:1000, 6% SDS-PAGE), anti-ACC antibody (#3662, Cell Signaling, 1:500, 6% SDS-PAGE), anti-phospho-AMPKα (Thr172) (40H9) antibody (#2535, Cell Signaling, 1:1000, 12% SDS-PAGE), anti-AMPKα antibody (#2532, Cell Signaling, 1:1000, 10% SDS-PAGE), anti-AMPKβ1/2 (57C12) antibody (#4150, Cell Signaling, 1:1000, 12% SDS-PAGE), and anti-α-tubulin (T5168, Sigma, 1:5000), respectively. For detection of phosphorylated proteins, TBS-T (Tris-buffered saline and 0.1% Tween) was used instead of PBS-T.
Immunoblotting to detect ETC and Oxphos proteins in wild-type and ERRα null hearts was performed in a manner similar to that described above. Forty µg of tissue lysate was resolved on a 9% SDS-PAGE and transferred to nitrocellulose. Primary antibody incubations were performed overnight at 4 o C with the following antibody dilutions: SDHA (clone 2E3) monoclonal antibody (GTX14715, GeneTex, Inc., 1:5000), SDHB (clone 21A11) monoclonal antibody (GTX14714, GeneTex, Inc., 1:1000), 
Expression Profiling Analysis in WT versus ERRα Null Hearts
Triplicate microarray analyses of wild-type and ERRα null hearts were conducted at the McGill University and Génome Québec Innovation Centre using 10 µg of total RNA and hybridized to Affymetrix MOE430 2.0 GeneChIP arrays. In this study, the mean of the expression data obtained from the individual wild-type and ERRα null mice was determined to identify genes with altered levels of expression in the knockout mice versus their wild-type littermates obtained using MultiExperiment Viewer (MeV) version 3.1 software. A P value cutoff of ≤ 0.001 and a relative fold change (log2) cutoff of +/-0.5 were used and genes were classified by biological function based on GO annotation (http://fatigo.org/) and NCBI gene descriptions. For quantitative reverse transcription PCR, cDNA was prepared from the same total RNA prepared from the individual wild-type and ERRα null hearts sent for gene expression profiling. cDNA was obtained from 4 ug of total RNA by reverse transcription with Oligo(dT) primer, dNTPs, 5X 1 st strand buffer, DTT, RNase inhibitor, and Superscript II RNase H Reverse Transcriptase. cDNA obtained from the individual wild-type and ERRα null hearts were pooled and amplified using specific primers (Table S4 ) along with the SYBR PCR Master Mix (Qiagen) and a LightCycler instrument (Roche). Relative fold expression levels of the analyzed genes were normalized to β-actin levels in the wild-type and ERRα null hearts.
Immunofluorescence in Primary Ventricular Myocytes
Immunofluorescent detection of sarcomeric and cytoskeletal proteins was performed in rat neonatal cardiac myocytes expressing either GFP or ERRα (and GFP) via adenoviral expression vectors. Cardiac myocytes cultured in chamber slides were infected with the appropriate adenovirus at 24h, then 96h post-infection were fixed for 15min with 4% formaldehyde in PBS. Fixed cells were blocked and permeabilized during 1h incubation in blocking buffer (1% immunoglobulin-free BSA, 3% normal goat serum, 0.15% triton X-100 in PBS) followed by overnight incubation (4 o C with rocking) with primary antibodies: α-tubulin (clone 236-10501) monoclonal antibody (A-11126, Invitrogen-Molecular Probes, 1:400), α-actinin (clone EA-53) (A7811, Sigma, 1:200), troponin I (TnI, H-170) (sc-15368, Santa Cruz Biotechnology, 1:100). Cells were rinsed 4 times with PBS then incubated for 1h with the Alexa Fluor 568 conjugated goat anti-mouse or anti-rabbit IgG antibody 1:400 as secondary antibody. Fluorescence imaging was performed using a Zeiss Axiophot microscope and single-channel images were captured using AxioVision software.
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Figure S1. Genome-wide Promoter Occupancy of ERRα and γ in Cardiac Tissue
Chromosomal distribution of ERRα and γ target genes identified in the adult mouse heart. The location of promoters found to be targets of ERRα, ERRγ or common to both ERRα and γ at a cutoff of P value ≤0.01 is indicated by blue, magenta and orange marks, respectively.
Figure S2. Validation of ERRα and γ Target Binding Sites
Standard ChIP validation of ERRα and γ ChIP-on-chip target genes in mouse heart at a cutoff of p ≤ 0.02. The majority of promoters found to be bound by either ERRα, ERRγ or by both nuclear receptors in the ChIP-on-chip experiments were found to be occupied by both receptors (≥2-fold enrichment) when tested by standard ChIP assays. The results shown are from one experiment based on three independent immunoprecipitations prepared from a pool of 20 hearts. 
Figure S5. Hearts Null for ERRα Exhibit Modest Effects on Expression of Enzymes Involved in Mitochondrial ATP Synthesis
Protein lysates from wild-type and ERRα null hearts were hybridized with antibodies against subunits of ETC Complex I, Ndufs3 and Ndufa9; Complex II, SDHA (flavoprotein) and SDHB (Fe-S protein); cytochrome c; Complex V, F 1 -ATPase; and proteins involved in coupling ATP synthesis with ADP transport and phosphate transfer, voltage-dependent anion channel 1 (VDAC1), sarcomeric mitochondrial creatine kinase (mtCK2), adenine nucleotide translocator 1 (ANT1). These data are consistent with the conclusion that ERRα and γ have overlapping regulatory functions in heart. In the absence of ERRα, γ and PGC-1α, both of which are up-regulated in ERRα null hearts, likely maintain expression of critical genes. Zinc finger, HIT domain containing 1 x Cellular functional classifications were based on GO annotation (http://fatigo.org/) and NCBI gene descriptions. Hypothetical genes and genes without an assigned function are not shown. ERRα and ERRγ columns marked with « x » indicates ERRα or ERRγ targets, respectively. Incidences where individual loci could be assigned to two distinct genes, both genes were included in the functional analysis. 
